Resistell, EPFL spinoff, located on the brand new 5th floor in Muttenz, is developing world’s fastest antibiotic susceptibility test to help the physicians around the world save patients lives. Our solution is needed more than ever in the context of global pandemics. Last year we have secured CHF 3.5 M in equity financing and won Innosuisse and Eurostars grants. Our core team counts 10 people and we expect to grow further in the next months. Last year we were 34th and among top 5 newcomers on the Top 100 Swiss Startups list. Help us climb faster to the top! Vote now!